Literature DB >> 24330519

Little evidence of a role for the α1GABAA subunit-containing receptor in a rhesus monkey model of alcohol drinking.

Eileen K Sawyer1, Casey Moran, Madelynn H Sirbu, Melissa Szafir, Michael Van Linn, Ojas Namjoshi, V V N Phani Babu Tiruveedhula, James M Cook, Donna M Platt.   

Abstract

BACKGROUND: Alcohol potentiates GABAergic neurotransmission via action at the GABAA receptor. α1 subunit-containing GABAA receptors have been implicated as mediators, in part, of the behavioral and abuse-related effects of alcohol in rodents.
METHODS: We systematically investigated the effects of 1 α1-preferring benzodiazepine agonist, zolpidem, and 2 antagonists, β-carboline-3-carboxylate-tert-butyl ester (βCCT) and 3-propoxy-β-carboline hydrochloride (3-PBC), on oral self-administration of alcohol (2% w/v) or sucrose solution and observable behavior in rhesus macaques. We compared these effects to those of the nonselective benzodiazepine agonist triazolam, antagonist flumazenil, and inverse agonist β-carboline carboxylate (βCCE).
RESULTS: Alcohol and sucrose solutions maintained reliable baseline drinking behavior across the study. The α1-preferring compounds did not affect intake, number of sipper extensions, or blood alcohol levels (BALs) at any of the doses tested. Zolpidem, βCCT, and 3-PBC increased latency to first sipper extension in animals self-administering alcohol, but not sucrose, solution. Triazolam exerted biphasic effects on alcohol-drinking behavior, increasing intake at low doses but decreasing BAL and increasing latency at higher doses. At doses higher than those effective in alcohol-drinking animals, triazolam increased sucrose intake and latency. Flumazenil nonsystematically increased number of extensions for alcohol but decreased BAL, with no effects on sucrose drinking. βCCE decreased sipper extensions for alcohol and increased latency for first sucrose sipper extension, but full dose-effect relationships could not be determined due to seizures at higher doses.
CONCLUSIONS: Alcohol-drinking animals appeared more sensitive to the effects of GABAergic compounds on drinking behavior. However, these results do not support a strong contribution of α1GABAA receptors to the reinforcing effects of alcohol in primates.
Copyright © 2013 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol; GABAA Receptors; Monkey; Pharmacotherapy; Self-Administration

Mesh:

Substances:

Year:  2013        PMID: 24330519      PMCID: PMC3984357          DOI: 10.1111/acer.12320

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  42 in total

1.  Mechanism of action of the hypnotic zolpidem in vivo.

Authors:  F Crestani; J R Martin; H Möhler; U Rudolph
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Association of GABA(A) receptors and alcohol dependence and the effects of genetic imprinting.

Authors:  Jiuzhou Song; Daniel L Koller; Tatiana Foroud; Kristie Carr; Jinghua Zhao; John Rice; John I Nurnberger; Henri Begleiter; Bernice Porjesz; Tom L Smith; Marc A Schuckit; Howard J Edenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-02       Impact factor: 3.568

Review 3.  Subunit composition, distribution and function of GABA(A) receptor subtypes.

Authors:  W Sieghart; G Sperk
Journal:  Curr Top Med Chem       Date:  2002-08       Impact factor: 3.295

4.  Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors.

Authors:  Elisabetta Cagetti; Jing Liang; Igor Spigelman; Richard W Olsen
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

5.  Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.

Authors:  Donna M Platt; James K Rowlett; Roger D Spealman; James Cook; Chunrong Ma
Journal:  Psychopharmacology (Berl)       Date:  2002-09-04       Impact factor: 4.530

6.  Role of GABAA/benzodiazepine receptors containing alpha 1 and alpha 5 subunits in the discriminative stimulus effects of triazolam in squirrel monkeys.

Authors:  Snjezana Lelas; James K Rowlett; Roger D Spealman; James M Cook; Chunrong Ma; Xiaoyan Li; Wenyuan Yin
Journal:  Psychopharmacology (Berl)       Date:  2002-03-13       Impact factor: 4.530

7.  Anticonflict and reinforcing effects of triazolam + pregnanolone combinations in rhesus monkeys.

Authors:  Bradford D Fischer; James K Rowlett
Journal:  J Pharmacol Exp Ther       Date:  2011-03-16       Impact factor: 4.030

8.  Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors.

Authors:  James K Rowlett; Roger D Spealman; Snjezana Lelas; James M Cook; Wenyuan Yin
Journal:  Psychopharmacology (Berl)       Date:  2002-11-06       Impact factor: 4.530

9.  The GABA(A) receptor alpha1 subtype in the ventral pallidum regulates alcohol-seeking behaviors.

Authors:  Scott C Harvey; Katrina L Foster; Pete F McKay; Michelle R Carroll; Regat Seyoum; James E Woods; Collette Grey; Cecily M Jones; Shannan McCane; Rancia Cummings; Dynesha Mason; Chunrong Ma; James M Cook; Harry L June
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

10.  Suggestive linkage on chromosome 1 for a quantitative alcohol-related phenotype.

Authors:  Danielle M Dick; John Nurnberger; Howard J Edenberg; Alison Goate; Ray Crowe; John Rice; Kathleen K Bucholz; John Kramer; Marc A Schuckit; Tom L Smith; Bernice Porjesz; Henri Begleiter; Victor Hesselbrock; Tatiana Foroud
Journal:  Alcohol Clin Exp Res       Date:  2002-10       Impact factor: 3.455

View more
  7 in total

1.  Reinforcing effectiveness of midazolam, ethanol, and sucrose: behavioral economic comparison of a mixture relative to its component solutions.

Authors:  E Andrew Townsend; Donna M Platt; James K Rowlett; Peter G Roma; Kevin B Freeman
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

2.  Effects of the benzodiazepine GABAA α1-preferring antagonist 3-isopropoxy-β-carboline hydrochloride (3-ISOPBC) on alcohol seeking and self-administration in baboons.

Authors:  August F Holtyn; V V N Phani Babu Tiruveedhula; Michael Rajesh Stephen; James M Cook; Elise M Weerts
Journal:  Drug Alcohol Depend       Date:  2016-11-04       Impact factor: 4.492

3.  Alcohol-induced changes in the gut microbiome and metabolome of rhesus macaques.

Authors:  Xiao Zhang; Koji Yasuda; Robert A Gilmore; Susan V Westmoreland; Donna M Platt; Gregory M Miller; Eric J Vallender
Journal:  Psychopharmacology (Berl)       Date:  2019-03-22       Impact factor: 4.530

4.  GABAA Receptor Subtypes and the Abuse-Related Effects of Ethanol in Rhesus Monkeys: Experiments with Selective Positive Allosteric Modulators.

Authors:  Lais F Berro; Daniela Rüedi-Bettschen; Jemma E Cook; Lalit K Golani; Guanguan Li; Rajwana Jahan; Farjana Rashid; James M Cook; James K Rowlett; Donna M Platt
Journal:  Alcohol Clin Exp Res       Date:  2019-04-08       Impact factor: 3.455

5.  Synthesis of aza and carbocyclic β-carbolines for the treatment of alcohol abuse. Regiospecific solution to the problem of 3,6-disubstituted β- and aza-β-carboline specificity.

Authors:  V V N Phani Babu Tiruveedhula; Kashi Reddy Methuku; Jeffrey R Deschamps; James M Cook
Journal:  Org Biomol Chem       Date:  2015-11-21       Impact factor: 3.876

6.  Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for α3 subunit-containing GABAA receptors.

Authors:  Zhiqiang Meng; Lais F Berro; Eileen K Sawyer; Daniela Rüedi-Bettschen; Jemma E Cook; Guanguan Li; Donna M Platt; James M Cook; James K Rowlett
Journal:  J Psychopharmacol       Date:  2019-10-31       Impact factor: 4.153

7.  Treatment with zolpidem after ethanol administration potentiates the expression of ethanol-induced behavioral sensitization in mice.

Authors:  N R N Brandão; M Libarino-Santos; E A V Marinho; T S Oliveira; A L N Borges; A P Oliveira; D Oliveira-Campos; N Azevedo-Souza; V F L Santos; L F Berro; A J Oliveira-Lima
Journal:  Braz J Med Biol Res       Date:  2020-06-26       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.